학술논문

COVID‐19 as a trigger of acute attacks in people with hereditary angioedema.
Document Type
Article
Source
Clinical & Experimental Allergy. Jul2021, Vol. 51 Issue 7, p947-950. 4p. 2 Charts.
Subject
*COVID-19
*COUGH
*ANGIONEUROTIC edema
Language
ISSN
0954-7894
Abstract
8 Caballero T, Maurer M, Longhurst HJ, Aberer W, Bouillet L, Fabien V. Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema. Keywords: angiotensin-converting enzyme inhibitor; COVID-19; HAE; hereditary angioedema EN angiotensin-converting enzyme inhibitor COVID-19 HAE hereditary angioedema 947 950 4 06/30/21 20210701 NES 210701 Acute attacks could occur during the convalescent phase of COVID-19 illness, more commonly in patients with a history of frequent attacks. Nonetheless, it adds to the evidence that patients with a good HAE disease control are at low risk of developing angioedema attacks. [Extracted from the article]